LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Nagpur Unit-2 Injectable Manufacturing Facility.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

2071.4000 7.00 (0.34%)

NSE May 14, 2025 15:31 PM

38.71% Gain from 52W Low

Volume: 1.2M

Lupin Ltd.

30 Oct 2022

2071.40

0.34%

Company Update

LUPIN LTD. - 500257 - U.S. FDA Inspection Of The Company'S Nagpur Unit-2 Injectable Manufacturing Facility.

BSE India

U.S. FDA Inspection of the Company's Nagpur Unit-2 injectable manufacturing facility.

More from Lupin Ltd.

All Rapid Results

Recommended

Market closes higher, HAL's Q4 revenue beats Forecaster estimates by 13.5%

Trendlyne Marketwatch | 14 May 2025, 03:55PM

Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs

The Baseline | 14 May 2025, 09:48AM

Lupin expects normalization by September quarter